Category Specific RSS

News

Azure Healthcare secures 3-year supply contract to more than 30 US States

Australian healthtech company Azure Healthcare (ASX: AZV) is set to further stamp their footprint on the United States healthcare system with a 3-year extension of their supply agreement for the Company’s nurse call systems which service more than 30 states. 

The Tacera Pulse system is used to monitor nurse call alarms, collect alarm and response data as well as measure performance outcomes to audit patient outcomes with this new 3-year extension following on from a successful 5-year provision signed by one of the largest U.S. healthcare providers in 2013. 

“With the re-signing of another 3-year Product and Services agreement to such a leading and well-regarded healthcare organization, it gives me great pleasure to deliver this news to shareholders,” said Azure CEO, Clayton Astles. 

“That we have been able to secure such a relationship with one of the largest US healthcare providers, validates our strategic plan and product development roadmap. Our products continue to evolve to meet the market and we are standing out and building a reputation for our products. 

“The global healthcare industry will continue to grow steadily, and I look forward to bringing further confirmation to our shareholders that our growth strategy is rolling out successfully in 2020.”

Azure’s unnamed client is a NYSE listed company which reported more than US $7 billion in revenue for 2019 and will continue operating the Tacera IP nurse call system to approximately 130 healthcare facilities across more than 30 states

Beyond this major client in the United States, Azure supplies its call systems to more than 4,500 healthcare facilities through its global reseller network and is the largest manufacturer of call systems in the southern hemisphere. 

Following news of the 3-year extension, shares in AZV rose to a high of $0.115 in morning trade, a rise of 22% on the previous day’s close of $0.09. 

The agreement also continues a strong run for Azure which last month reported a higher earnings forecast than expected driven by uptake in its call systems as a result of the US-China tariff regime.

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago